The drug is derived from the foxglove plant (Digitalis purpurea), which was first described as a treatment for “dropsy” — now ...

India: A new study has found that among patients with symptomatic rheumatic heart disease, digoxin was associated with a ...

A trial by AIIMS shows digoxin may reduce worsening heart failure in rheumatic heart disease patients, offering a low-cost treatment option.

Heart failure (HF) patients who have reduced or mildly reduced ejection fraction derive better outcomes when low-dose digoxin ...

Digoxin, a cardiac glycoside derived from the foxglove plant, has been a mainstay of treatment in systolic heart failure and in rate control for atrial fibrillation. By inhibiting the cardiac ...

UB researchers have identified for the first time an enzyme in the foxglove plant that is responsible for the production of compounds needed to make the heart failure drug digoxin. The breakthrough ...

Digitalis glycosides may be a safe and tolerable addition to optimal guideline medical therapy to reduce worsening heart ...

Analyses supporting the use of digitalis glycosides in patients with heart failure were presented in a Late-Breaking Science session today at Heart Failure 2026.

Oct. 30, 2002 — Digoxin may pose a risk of death for women with heart failure, according to a retrospective analysis published in the Oct. 31 issue of the New England Journal of Medicine. Yet ...

Digoxin now deserves to be considered first-line therapy for long-term heart rate control in older patients with permanent atrial fibrillation and symptoms of heart failure, investigators on a new ...